Overview
Mn cofactor for SOD2 mitochondrial antioxidant defense.
- Whole foods (leafy greens, legumes, nuts, seeds, seafood, animal proteins)
- Fortified foods such as cereals, breads, plant milks, and table salt
- Mineral supplements as chelates, citrates, glycinates, or inorganic salts
- Chelated form (glycinate, bisglycinate, citrate, malate)
- Inorganic salt (oxide, sulfate, chloride)
- Liquid ionic solution
- Topical or transdermal preparation
Forms & variants of Manganese
Different chemical forms of Manganese behave differently. Browse each form's mechanism, bioavailability, and best-use context.
Mechanism of action
Required by MnSOD; cofactor for glycosyltransferases in bone matrix.
- · Required by MnSOD
- · cofactor for glycosyltransferases in bone matrix
Effects on the body
Organ system effects
Manganese (Extra) contributes to bone mineralization, osteoblast activity, or calcium-phosphate homeostasis.
Evidence-based benefits
Combined with Ca/Zn/Cu reduces bone loss
Moderate evidencePotential side effects
- · Neurotoxicity at extreme doses
Drug interactions
Supplement interactions
- A high-quality multivitaminCovers micronutrient cofactors that support most supplement pathways.
- Omega-3 (EPA/DHA)Foundational anti-inflammatory support that complements most regimens.
No specific avoidances listed.
Dosing & bioavailability
Where to buy
Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.
Scientific evidence8Show studiesHide studies
Trace minerals on bone density
Strause L, et al.
2-year DB-RCT in 59 postmenopausal women.
Ca + trace minerals (incl Mn) preserved spinal BMD vs Ca alone.
PubMed: Manganese (Extra) — Combined with Ca/Zn/Cu reduces bone loss
Live PubMed search
Live results for "Manganese (Extra) Combined with Ca/Zn/Cu reduces bone loss" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Manganese (Extra) and "Combined with Ca/Zn/Cu reduces bone loss". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Manganese (Extra) — randomized controlled trial
Live PubMed search
Live results for "Manganese (Extra) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Manganese (Extra) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Manganese (Extra) — meta-analysis
Live PubMed search
Live results for "Manganese (Extra) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Manganese (Extra) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Manganese (Extra) — pharmacokinetics
Live PubMed search
Live results for "Manganese (Extra) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Manganese (Extra) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Manganese (Extra) — safety adverse events
Live PubMed search
Live results for "Manganese (Extra) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Manganese (Extra) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Manganese (Extra) — dose response
Live PubMed search
Live results for "Manganese (Extra) dose response" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Manganese (Extra) and "dose response". Filter by RCT, meta-analysis, or year on the results page.
Google Scholar: Manganese (Extra) — clinical evidence
Live Scholar search
Cross-database citation index for Manganese (Extra) as it relates to "clinical evidence".
Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.